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ABSTRACT
3-(5-H/Me/Cl/NO2-1H-benzimidazol-2-yl)-benzene-1,2-diols (HLX; X = 1–4) ligands and HL3 complexes with Fe(NO3)3, Cu(NO3)2,
Co(NO3)2, Zn(NO3)2 have been synthesized and characterized. The structural representations of the compounds are proposed on
the basis of elemental analysis, molar conductivity, TGA, mass, FT-IR, 1H- and 13C-NMR spectrometry. All of the complexes are 1:1
electrolyte and have 1:1 M:L ratio except that of Cu(II).All of the complexes present fluorescence, the Co(II) complex showing
the highest fluorescence intensity and the highest emission wavelength in comparison to the other complexes. Antibacterial
activities of the ligands and the complexes formed by the HL3 ligand were evaluated using the disk diffusion method against six
bacteria and Candida albicans. HL1, HL2, HL3 and [Cu(HL3)( )(H2O)2](NO3)·H2O show considerable antimicrobial activity toward
S. epidermidis and C. albicans.
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1. Introduction
Benzimidazolyl-phenol ligands are known to be strong
chelating agents. These ligands are potential N,O donors and
they react easily with metal ions to give stable chelate complexes.
Various transition metal chelate complexes of benzimidazolyl-
phenol type ligands have been reported.1–15
In our previous studies, a series of benzimidazolyl-phenol
ligands and their metal complexes were synthesized, and their
antimicrobial activities were investigated. For example,
2-methoxy-6-(5-H/methyl/chloro/nitro-1H-benzimidazol-2-yl)-
phenol ligands and some transition metal complexes were
synthesized and characterized. Some of the mentioned ligands,
and Cu(II) and Zn(II) complexes showed antibacterial activity
against Gram+ bacteria.16 It has also been reported that
4-methoxy-2-(1H-benzimidazol-2-yl)-phenol and the correspond-
ing Ag(I) and Cu(II) complexes are effective on S. epidermidis, S.
aureus and B. subtilis. Also, 4-methoxy-2-(5-methyl/chloro-
1H-benzimidazol-2-yl)-phenols showed antibacterial activity
toward S. aureus.17 While 2-methyl-6-(1H-benzimidazol-2-yl)-
phenol had no activity, the corresponding Ag(I) and Zn(II)
complexes showed antibacterial activity toward K. pneumoniae,
S. epidermidis and S. aureus bacteria.18 2-(5-Nitro-1H-benzi-
midazol-2-yl)-4-bromophenol and their Cu(II) and Fe(III)
complexes showed considerable antibacterial activity against S.
epidermidis relative to Ciprofloxazin.19 2-(5-H/Me/Cl-1H-benzi-
midazol-2-yl)-phenols, 2-(5-H/Me-1H-benzimidazol-2-yl)
-4-bromo/nitro-phenols and their Fe(III) and Zn(II) complexes
showed broad-spectrum (Gram+ and Gram– bacteria) activ-
ity.13,20,21
In this work, 3-(5-H/methyl/chloro/nitro -1H-benzi-
midazol-2-yl)-benzene-1,2-diols (HLX; X = 1–4) ligands (Fig. 1)
and the (Fe(III), Cu(II), Co(II) and Zn(II) complexes with
3-(5-chloro-1H-benzimidazol-2-yl)-benzene-1,2-diol (HL3) are
reported. Herein, we discuss the characterizations of the
compounds and the structural–biological activity relationship of
the ligands and the complexes.
2. Experimental
All chemicals and solvents were reagent grade and were used
as purchased without further purification. Melting points were
determined using an Electrothermal melting-point apparatus.
Analytical data were obtained with a Thermo Finnigan Flash
EA 1112 analyzer. Molar conductivities of the complexes were
measured on a WTW Cond315i conductivity meter in dimethyl
sulfoxide (DMSO) at 25 °C. 1H- and 13C-NMR spectra were
recorded on a Varian Unity Inova 500 NMR spectrometer. The
residual DMSO-d6 signal was used as an internal reference. Solid
FT-IR spectra were recorded using KBr disks on a Mattson 1000
FT-IR spectrometer. The electron spray ionization (ESI) MS anal-
yses were carried out in positive ion modes using a Thermo
Finnigan LCQ Advantage MAX LC/MS/MS. Thermogravimetric
(TG) analyses were made on a TG-60WS Shimadzu, with a heat-
ing rate of 10 °C min–1 under flowing air at the rate of 50 mL min–1.
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Figure 1 Structural representation of the ligands.
R = H, HL1; R = CH3, HL2; R = Cl, HL3; R = NO2, HL4
Magnetic measurements were carried out on a Sherwood Scien-
tific apparatus (MK1) at room temperature using Gouy’s method.
Fluorescence spectra were performed on a Shimadzu RF-5301 PC
Spectrofluorophotometer.
2.1. Synthesis of the Ligands: General Procedure
The ligands were prepared according to literature proce-
dures.7,22 For instance, 3-(5-chloro-1H-benzimidazol-2-yl)-ben-
zene-1,2-diol (HL3) was obtained by reaction of 2,3-dihydroxy-
benzaldehyde (1.38 g, 10 mmol) and the equivalent amount of
NaHSO3 (1.04 g, 10 mmol) at room temperature in 25 mL ethanol
for 4–5 h. The mixture was treated with 4-chloro-1,2-phenyl-
enediamine (1.43 g, 10 mmol) in 15 mL dimethylformamide and
gently refluxed for 2 h. The reaction mixture was then poured
into 500 mL icy water, filtered and crystallized from ethanol.
2.2. Synthesis of the Complexes
2.2.1. [Fe(L3)(OH)(H2O)3](NO3)
131 mg of HL3 (0.502 mmol) in ethanol (10 mL) was treated with
202 mg Fe(NO3)3·9H2O (0.500 mmol) in ethanol (5 mL) at ~60 °C
for 2 h. The solution mixture was allowed to stand at ~4 °C for
several days, until a black solid product precipitated, which was
collected by filtration and dried under vacuum over CaCl2.
2.2.2. [Co(L3)(H2O)2](NO3)
131 mg of HL3 (0.502 mmol) and 146 mg of Co(NO3)2·6H2O
(0.502 mmol) were reacted in ethanol (10 mL). After 8 h reflux the
black precipitate was filtered and dried under vacuum over
CaCl2.
2.2.3. [Cu(HL3)(L3)(H2O)2](NO3)·H2O
131 mg of HL3 (0.502 mmol) and 121 mg of Cu(NO3)2·3H2O
(0.501 mmol) were reacted in ethanol (10 mL). After 4 h reflux the
brown precipitate was filtered and dried under vacuum over
CaCl2.
2.2.4. [Zn(L3)(H2O)2](NO3)
131 mg of HL3 (0.502 mmol) were suspended in ethyl acetate
(10 mL), and 149 mg of Zn(NO3)2·6H2O (0.501 mmol) in
ethylacetate (5 mL) was added to the ligand suspension. The
mixture was refluxed for 2 h. The brown precipitate was filtered
and dried under vacuum over CaCl2.
2.3. Determination of Antimicrobial Activity
Antimicrobial activity against Staphylococcus aureus ATCC 6538,
Staphylococcus epidermidis ATCC 12228, Escherichia coli ATCC 8739,
Klebsiella pneumoniae ATCC 4352, Pseudomonas aeruginosa
ATCC 27853, Proteus mirabilis ATCC 14153 and Candida albicans
ATCC 10231 were determined by the micro broth dilutions
technique strictly following the National Committee for Clinical
Laboratory Standards (NCCLS) recommendations.23,24 Mueller-
Hinton broth for bacteria, RPMI-1640 medium, buffered to pH 7.0
with MOPS for yeast strain was used as the test medium. Serial
two-fold dilutions ranging from 5000 µg mL–1 to 4.9 µg mL–1 were
prepared. The inoculum was prepared using a 4–6 h broth
culture of each bacteria and 24 cultures of yeast strains adjusted
to a turbidity equivalent to a 0.5 McFarland standard, diluted in
broth media to give a final concentration of 5 ! 105 cfu mL–1 for
bacteria and 0.5 ! 103 to 2.5 ! 103 cfu mL–1 for yeast in the test
tray. The trays were covered and placed in plastic bags to prevent
evaporation. The trays containing Mueller-Hinton broth were
incubated at 35 °C for 18–20 h and the trays containing RPMI-
1640 medium were incubated at 35 °C for 46–50 h. The minimum
inhibitory concentrations (MIC) were defined as the lowest
concentration of compound giving complete inhibition of visible
growth. Ciprofloxacin and sodium cefuroxime were used as
reference antimicrobials for bacteria and yeast, respectively. As
control, antimicrobial effect of solvent (DMSO) was investigated
against test microorganisms.
3. Results and Discussion
3.1. Physical Properties
The analytical data and physical properties of the ligands and
the complexes are summarized in Table 1.
All the complexes are quite stable and could be stored for
months without any appreciable change. The complexes do not
have sharp melting points but decompose above 350 °C.
The molar conductivity values of the complexes are 32, 34, 42
and 43 t–1 cm2 mol–1 for the Fe(III), Co(II),Cu(II) and Zn(II)
complexes, respectively. These results are indicative of 1:1
electrolyte complexes.
It is known that the solvent plays a considerable role in
complexation.25,26 In this study, Fe(III) and Cu(II) easily
complexed with HL3 whereas Co(II) was able to complex at the
end of an 8 h period. All the reactions were done in ethanol.
However, Zn(II) did not complex with the ligand in ethanol, due
to the strong intramolecular hydrogen bonding between the OH
hydrogen and C = N nitrogen atom present in the ligand. This
fact can be explained as follows: Zn(II) ion is a borderline Lewis
acid, and it cannot overcome the intramolecular hydrogen
bonding and the complex cannot form. Therefore, the
complexation reaction of HL3 with Zn(II) occurs with a high
yield in ethyl acetate because of the good solubility of both the
ligand and Zn(NO3)2·6H2O in it.
3.2. Magnetic Moments
The room temperature magnetic moment value of
[Fe(L3)(OH)(H2O)3](NO3) complex is 3.90 BM, which is lower
than the spin only value ~5.90 BM for Fe(III) d5 with S = 5/2 (high
spin under a weak crystal field) and higher than the spin only
value of ~2.0 BM in the case of S = 1/2 (low spin in the presence
of a strong crystal field). The intermediate values of the magnetic
moment indicate stabilization of the species having
intermediate ferric spin (S = 3/2) state for this complex.27,28
The magnetic moment value of the Cu(II) complex is 1.86 BM,
which is in the expected range for mononuclear d9 (e.g. Cu2+)
complexes.
The observed magnetic moment value for the Co(II) complex,
4.38 BM, lies in the range reported for tetrahedral Co(II)
complexes having three unpaired electrons.29 This value is high
for that of three unpaired electrons (3.87 BM). The electronic
configuration of a tetrahedral Co(II) complex is (dx2-y2)2 (dz2)2 (dxy)1
(dyz)1 (dxz)1. It is known that both tetrahedral and high-spin octa-
hedral Co(II) complexes possess three unpaired electrons but
may be distinguished by the magnitude of the deviation of µeff
from the spin-only value. The magnetic moment of tetrahedral
Co(II) complexes with an orbitally nongenerate ground term is
increased above the spin-only value via contribution from
higher orbitally degenerate terms and occurs in the range 4.2–
4.7 BM.30
3.3. FT-IR Spectra
FT-IR spectral data of the ligands and the complexes are given
in Table 2. The characteristic å(O–H) and å(N–H) vibration
frequencies of the ligands exhibit strong or medium bands at
ca. 3400 and 3300 cm–1, respectively.20,31,32 These bands change
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significantly upon metal complexation indicating deproto-
nation and subsequent involvement of the phenoxyl group in
metal coordination. The phenolic oxygen atom coordination is
supported by the appearance of medium bands at a lower
frequency region ca. 500 cm–1, assignable to å(M–OC) vibration
frequencies.33
Appearance of the broad bands above 3400 cm–1 in the com-
plexes may be due to the å(N–H) (and stretching of uncoordi-
nated water molecules for Cu(II) complex) vibration frequencies.
The characteristic å(C–H) and Ç(C–H) modes of ring residues
and aliphatic groups (methyl and methoxy) are observed in the
wavenumber region between 3200–2940 cm–1 and 900–700 cm–1
(Table 2). The å(C = C) frequencies for the ring residue are
expected to appear at ca. 1630 cm–1 with their own characteristics
for the ligands in the IR spectra. Similarly the (C = N) asymmet-
ric stretching frequencies are expected to appear at ca. 1600 cm–1.
This IR band is observed at 1591 cm–1 in HL3 ligand and shifts to
higher frequencies in the complexes. This shift may support the
argument that coordination occurs via the imine nitrogen atom.
Intra- or intermolecular H-bonding was observed in the IR
spectra of the ligands, between 2900–2500 cm–1 as broad bands.
The sequence of intramolecular hydrogen bonding from the
strongest to the weakest was: HL4>HL3>HL2ŸHL1. HL4 was
expected to have the strongest H-bonding because of the nitro
group.
All of the complexes show strong bands at ca. 1385 cm–1 in their
IR spectra, supporting the presence of uncoordinated nitrate
ion, which was also confirmed by conductivity data.25,34,35
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Table 2. IR spectral data of HL1–HL4 and the complexes of HL3.
Compound Frequency /cm–1
HL1 3389 sa, 3282 s, 3138 m,br, 1667 m, 1630 m, 1603 m, 1511 m, 1439 s, 1413 m, 1271 s, 1231 m, 1017 m, 915 m, 859 m, 790 m, 736 s,
673 m, 596 m, 438 m
HL2 3437 m,br, 3284 m, 3179 m,br, 2921 w, 1656 m, 1623 m, 1568 m, 1510 m, 1439 m, 1401 m, 1314 m, 1273 s, 1237 m, 1142 m,
1008 m, 900 m, 845 m, 791 m, 732 m, 653 m, 594 m, 528 m, 436 m
HL3 3376 m,br, 3293 s, 2938 m, 1628 m, 1591 m, 1538 m, 1482 s, 1425 m, 1385 m, 1256 s, 1057 m, 936 m, 790 m, 733 m, 608 m, 515 m
HL4 3436 s, 3278 s, 3084 m, 1640 m, 1595 m, 1518s, 1472m, 1388 m, 1334 s, 1276 m, 1247 m, 1071 m, 1000 m, 900 m, 796 m, 740 m,
649 m, 599 m, 553m, 436m
[A] b 3406 m,br, 3254 m,br, 3114 m,br, 1635 m, 1613 m, 1563 m, 1534 m, 1480 m, 1385 s, 1284 m, 1239 m, 1070 m, 1025 m, 928 m,
813 m, 718 m, 680 m, 599 m, 493 m
[B] 3550–3100 m,br, 1626 m, 1613 sh, 1559 m, 1475 m, 1429 m, 1384 s, 1284 m, 1236 m, 1213 m, 1103 m, 1065 m, 927 m, 807 m,
723 m, 598 m, 509 m, 473 w
[C] 3453 m,br, 3196 m,br, 1626 m, 1607 m, 1540 m, 1482 m, 1432 m, 1386 s, 1277 m, 1214 m, 1069 m, 1033 m, 944 m, 806 m, 733 m,
598 m
[D] 3600–3100 m,br, 1623 m, 1610 m, 1559 s, 1542 m, 1507 m, 1385 s, 1309 m, 1281 m, 1065 m, 1040 m, 934 m, 805 m, 714 m, 598 m,
487 m
a s, strong; m, medium; br, broad; sh, shoulder, w, weak.
b [A]:[Fe(L3)(OH)(H2O)3](NO3);[B]: [Co(L3)(H2O)2](NO3); [C]: [Cu(HL3)(L3)(H2O)2](NO3)·H2O; [D]:[Zn(L3)(H2O)2](NO3).
Table 1 The analytical data and physical properties of HL1–HL4 and the complexes.
Compound Found (calcd) % Yield % M.p.(dec.) a i b Colour
C H N
HL1 68.8 4.7 12.1 62 225 – Colourless
C13H10N2O2 (69.0) (4.5) (12.4)
HL2 70.3 5.3 11.4 66 182 – Colourless
C14H12N2O2 (70.0) (5.0) (11.7)
HL3 59.9 3.7 10.4 Light yellow
C13H9ClN2O2 (59.9) (3.5) (10.7) 71 221 –
HL4 57.4 3.5 15.5 58 323 – Yellow
C13H9N3O4 (57.6) (3.3) (15.5)
[Fe(L3)(OH)(H2O)3](NO3)c 35.3 3.1 9.0 75 >350 32 Black
C13H15ClFeN3O9 (34.8) (3.4) (9.4)
[Co(L3)(H2O)2](NO3)c 37.8 3.3 10.4 70 >350 34 Black
C13H12ClCoN3O7 (37.5) (2.9) (10.1)
[Cu(HL3)(L3)(H2O)2](NO3)c 45.0 3.6 10.4 67 >350 42 Brown
·H2O; C26H22Cl2CuN5O10 (44.7) (3.3) (10.0)
[Zn(L3)(H2O)2](NO3) 37.3 3.2 9.9 85 >350 43 Brown
C13H12ClN3O7Zn (36.9) (2.9) (9.9)
a dec., decomposed,  °C.
b
i, molar conductivity, t–1 cm2 mol–1 (25 °C).
c µeff values for Fe(III), Cu(II) and Co(II) complexes are 3.90, 1.86 and 4.38 BM, respectively.
3.4. NMR Spectra
The 1H- and 13C-NMR spectral data of the ligands and
[Zn(L3)(H2O)2](NO3) complex are given in Tables 3 and 4, respec-
tively. The OH proton at 1’-position (OH1) appears between 9.08
and 9.41 ppm in the ligands. The OH2 (at 2’-position) and
NH protons show broad singlets in the spectra of HL1, HL2
and HL4. This situation is due to the strong intramolecular
hydrogen bonding between the C = N nitrogen and phenolic
hydrogen atoms. However, the OH2 and NH protons of HL3
appear separately in the NMR spectrum probably due to two
isomeric structures as shown in Fig. 2. The isomeric structures
are observed for the benzimidazole protons only (Fig. 3 and
Table 3). The integration value of the broad signals at 7.72 and
7.80 ppm show that each of them corresponds to 0.5 protons.
These signals can be attributed to H7 (isomer B) and H4
(isomer A) protons, respectively.36
Benzimidazole benzene ring protons appear in the 6.81–8.56
ppm range. In the 1H-NMR spectrum of HL1, two doublets of
doublets of AA’XX’ system at ÇH 7.65 (2H) and 7.27 (2H) ppm are
attributed for the benzimidazole benzene ring protons.
There are considerable differences between HL4 and the other
benzimidazole derivatives in terms of benzimidazole protons
in the 1H-NMR spectra because of the nitro group’s strong
withdrawing effect. For example, H4 appears at 8.56 ppm (this
value is 7.80, 7.65 and 7.56 ppm for HL3, HL1 and HL2, respec-
tively). The other benzimidazole protons (H3, H5 and H6)
and NH proton of HL4 exhibit different chemical shift values to
those of the other ligands.
In the 1H-NMR spectrum of the Zn(II) complex, some promi-
nent changes are observed in the characteristics of the phenolic
and benzimidazole benzene ring protons with respect to the
ligand. For instance, two doublets of doublets (7.49 and
6.92 ppm) and the singlet (9.20 ppm) coalesce to broad singlet,
whereas the triplet at 6.84 ppm of the ligand turns into a broad
multiplet because of strong metal ion’s perturbing effect. On the
other hand, the broad singlet at 13.27 ppm for the NH proton in
the spectra of HL3 changed to a singlet (13.21 ppm) in the com-
plex probably due to removing of the intramolecular hydrogen
RESEARCH ARTICLE A. Tavman, A.S. Birteksoz and F. Oksuzomer, 153
S. Afr. J. Chem., 2012, 65, 150–158,
<http://journals.sabinet.co.za/sajchem/>.
Table 4. 13C-NMR (APT) spectral data of HL1–HL4 and [Zn(L3)(H2O)2](NO3) ( C, ppm; in DMSO-d6).
Compound Quaternary carbons H-bonded carbons
HL1 152.7, 147.6, 146.8, 113.1 119.4, 117.9, 116.7
HL2 147.7, 146.9, 113.4 119.5, 117.9, 116.7, 22.0 a
HL3 154.1, 147.7, 147.0, 127.8, 113.2 123.7, 119.7, 119.5, 118.4, 117.1
HL4 156.8, 147.8, 147.1, 143.7, 113.1 120.0, 119.1, 118.9, 117.8
[Zn(L3)(H2O)2](NO3) 168.3, 163.8, 130.7, 96.8 125.0, 116.2
a CH3.
Figure 2 Isomeric structural representation for HL3 ligand.
Table 3 1H-NMR spectral data of HL1–HL4 and [Zn(L3)(H2O)2](NO3) (ÇH, ppm; in DMSO-d6).
Compound Benzimidazole protons Phenolic protons
H4 H5 H6 H7 NH H6’ H5’ H4’ OH1 OH2
HL1 7.65 7.27 7.27 7.65 13.01 6.91 dd 6.81 t 7.49 dd 9.22 13.01
m a m m m s,br 1.6,7.7 7.7,7.8 J = 7.6,1.5 s,br s,br
HL2 7.56 2.45 b 7.46 dd 7.38 12.98 6.89 dd 6.81 t 7.10 d,br 9.08 12.98
s,br s J = 1.5,7.8 s,br s,br J = 8.3,1.5 J = 7.8,8.3 J = 7.3 s,br s,br
HL3 7.80 –– 7.49 dd 7.61 13.27 6.92 dd 6.84 t 7.30 9.2 12.78
(isomer A) s,br J = 1.5,8.3 s,br s,br J = 1.5,7.8 J = 7.8,8.3 s,br s s,br
HL3 7.49 dd 7.61 –– 7.72 13.27 6.92 dd 6.84 t 7.30 9.2 12.78
(isomer B) J = 1.5,8.3 s,br s,br s,br J = 1.5,7.8 J = 7.8,8.3 s,br s s,br
HL4 8.56 –– 8.18 d 7.82 13.61 6.97 d 6.86 dd 7.54 d 9.41 12.35
s J = 8.8 d,br s,br J = 7.6 J = 7.6,7.6 J = 7.6 s s,br
[A]c 7.89 –– 7.56 7.86 d,br 13.21 7.31 7.31 7.52 d 8.63 ––
s,br s,br J = 5.8 s m,br m,br J = 8.3 s,br
a s, singlet; d, doublet; dd, doublet of doublet; m, multiplet; br, broad.
b 3H (CH3).c[A]: [Zn(L3)(H2O)2](NO3).
bonding as a result of the complexation. The broad singlet at
8.63 ppm belongs to OH1 in the complex spectrum, which
appears at 9.20 ppm in the spectrum of the ligand. The OH2
proton’s signal in the 1H-NMR spectrum of the Zn(II) complex is
removed as expected. This observation is evidence of the OH
hydrogen’s eliminating and the phenolic oxygen’s coordinating
to the Zn(II) ion.
In the APT spectra of the ligands all of the carbons could not be
detected. However, assignment of some signals could be made:
The signals above 150 ppm may be assigned to the C2 carbon
atom which is attached to the two imidazole nitrogen atoms
(N = C–N).16–18,37 The signals around 147 ppm in the ligands are
attributed to the C1’ and C2’ atoms which are bonded to the OH
groups.38–40
Good quality NMR spectra for the [Zn(L3)(H2O)2](NO3)
complex could not be recorded because of its very low solubility
in DMSO-d6 and in other polar solvents such as methanol
and DMF. This property may be considered as evidence for a
polymeric structure.
3.5. Mass Spectra
The ESI-MS spectral data of HL3 and its complexes are given in
Table 5 as molecular ions with the relative abundance.
It is known that chlorine, bromine and copper have two
isotopes: These isotopes, their percent abundance and approxi-
mately relative proportions are: 35Cl(75.8 %): 37Cl(24.2 %) (3:1);
79Br(50.7 %): 81Br(49.3 %) (1:1); 63Cu(69.2 %): 65Cu(30.8 %) (2:1). On
the other hand, zinc has five [64Zn(48.63 %); 66Zn(27.90 %);
67Zn(4.10 %); 68Zn (18.75 %); 70Zn(0.62 %)] and iron has four
isotopes [54Fe (5.84 %); 56Fe(91.75 %); 57Fe(2.12 %); 58Fe(0.28 %)]
whereas only one isotope is known for cobalt (59Co).
A series of isotopic patterns were identified for the metal
complexes of HL3 due to various isotopes of the chlorine and the
central atoms in the complexes (except cobalt). For example, in
the mass spectra of [Zn(L3)(H2O)2](NO3) complex, six isotopic
patterns are observed for the molecular ion (Table 5). On the
other hand, two significant peaks appear in the spectra of Fe(III)
complex for the molecular ion, as expected. These two isotopic
patterns arise entirely from chlorine atoms although iron has
four isotopes: 56Fe (with 91.75 % relative abundance) is a unique
dominant isotope among of isotopes of iron. Since the percent-
age of the other three isotopes is insignificant.
Ligand peaks are easily seen in the mass spectra of the com-
plexes (the ligand is shown as L3 in Table 5).
3.6. Thermogravimetric Analyses
The major features of the thermal analysis of the complexes are
summarized in Table 6. TGA curves of the complexes are shown
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Figure 3 1H-NMR spectrum of HL3 between 6.7 and 7.9 ppm (aromatic region) showing isomerism.
Table 5. ESI-MS spectral data of HL3 and its complexes.
Compound and MW (g/mol) Molecular ions (m/z) with relative abundance (%) and isotopic patterns
HL3 259.2 (100, [M-2]+ {35Cl}), 260.3 (11.0, [M]+, {35Cl+37Cl}), 261.2 (26.6, [M+1]+ {37Cl}), 262.2 (3.6, [M+2]+)
260.7
[Fe(L3)(OH)(H2O)3](NO3) 450.4 (6.9, [M+2]+), 452.3 (3.2, [M+4]+), 350.2 (100, [M-NO3-3H2O]+), 258.1 ([ML3-3]+)
448.6
[Co(L3)(H2O)2](NO3) 412.4 (36.2, [M-4]+ {37Cl}), 414.6 (100, [M-2]+ {35Cl}), 416.7 (19.2, [M]+), 354.6 (43.4, [M-NO3]+), 338.4 (28.4,
416.6 [M-NO3-H2O-2]+), 261.1 (19.2, [ML3]+)
[Cu(HL3)(L3)(H2O)2](NO3) 722.3 (100, [M+23]+), 723.2 (49.3, [M+23+1]+), 724.3 (12.2, [M+23+2]+), 663.9 (44.0, [M-2H2O]+), 261.2 (13.9,
·H2O; 698.9 [ML3]+)
[Zn(L3)(H2O)2](NO3) 421.6 (9.1, [M-2]+), 422.8 (7.3, [M-1]+), 423.6 (7.1, [M]+), 424.4 (6.8, [M+1]+); 425.3 (5.2, [M+2]+), 426.2 (4.3,
423.1 [M+3]+), 361.3 (100, [M-H2O-NO3]+), 259.7 (63.7, [ML3-2]+)
in Fig. 4. The samples of the complexes were heated from room
temperature up to 800 °C. Thermal analysis results exhibited the
valuable information about the water coordination state of the
complexes.
In the TG analysis of Co(II), Zn(II) and Fe(III) complexes there
is no significant weight loss until 120 °C; above 120 °C, the weight
losses being between 5.2–7.7 %. This finding serves as proof
of the nonexistence of uncoordinated water molecule in the
mentioned complexes. These findings are in line with the mass
and elemental analysis of the complexes. The coordinated water
molecules are removed from Fe(III), Co(II) and Zn(II) complexes
at temperatures between 110 and 150 °C.41,42 The weight loss
of 2.3 % for the Cu(II) complex below 100 °C corresponds to one
mole of uncoordinated lattice water (Table 6, first column).
Calculated percentage of one mole of water is 2.5 % for the Cu(II)
complex.
The sharp drop observed (weight loss of 38 %) in the 220–
240 °C range of the TGA curve of the Fe(III) complex is consider-
ably different from the other complexes. This difference can be
explained by the Fe(III) complex having a trivalent metal ion.
Fe(III) ion may be reduced easily by heating and begins to
decompose earlier than the others. The weight loss at this stage
can be explained in terms of the cleavage of the chlorine atom,
hydroxo and hydroxy groups and also as decomposition of
nitrate ion. Fe(III) complex above 400 °C and the others above
600 °C decompose to metal oxide, carbon dioxide and water. The
metal percentages of the complexes are calculated from the
residual percentage of metal oxide % formed in the final step
and are in good agreement with data obtained by the wet
combustion method of MacDonald.42,43
According to the TGA data, two water molecules coordinate to
the Cu(II) ion in [Cu(HL3)(L3)(H2O)2](NO3)·H2O. This complex
contains an uncoordinated water molecule, also. The presence
of a nitrate ion shows that OH1 hydrogen atom did not eliminate
from the second HL3 ligand of the Cu(II) complex. Namely, it
may be concluded that Cu(II) complex is a penta-coordinated
complex as depicted in Fig. 5 and in the literature.9
3.7. Fluorescence Spectra
Excitation and emission spectra of the compounds were
obtained in ethanol solution at room temperature (excitation
wavelength: 354 nm; concentration: 10–4 M). The emission
spectral data are presented in Table 7. The fluorescence spectra
of all the compounds in the study are shown in Fig. 6.
HL1 shows a strong emission band at 479 nm with a shoulder at
395 nm. The other ligands also have two emission bands, a main
band and a shoulder or weak band (at the lower wavelength)
(Table 7). Based on the excited state intramolecular proton
transfer (ESPT) theory, the fluorescence band at the lower wave-
length is attributed to the emission from the enol form of the
ligands, while the band at the higher wavelength is attributed to
the emission from the keto form of the ligands via an ESPT
process (Fig. 7). According to the ESPT process, it is possible to
say that all of the ligands exist in the keto form in ethanol.
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Table 6 TGA data of the complexes (thermal decomposition).
Temperature ( °C) Ã 100 150 200 250 300 350 400 450 500 550 600 >650
Complex Weight loss (%)
[A] a 1.9 5.6 12.0 53.5 54.7 72.6 78.1 80.5 80.8 81.2 81.7 82.3
[B] 2.0 5.2 11.7 8.3 23.2 29.1 37.7 50.1 59.0 72.5 83.7 84.1
[C] 2.3 7.0 12.2 18.5 22.5 27.3 34.5 46.9 56.4 77.1 87.5 87.7
[D] 2.1 7.7 10.0 12.6 18.3 28.6 36.2 43.8 57.9 68.2 80.7 83.4
a [A], [Fe(L3)(OH)(H2O)3](NO3); [B], [Co(L3)(H2O)2](NO3); [C], [Cu(HL3)(L3)(H2O)2](NO3)·H2O; [D], [Zn(L3)(H2O)2](NO3).
Figure 4 TGA curves of the complexes: 1: [Fe(L3)(OH)(H2O)3](NO3); 2: [Co(L3)(H2O)2](NO3); 3: [Zn(L3)(H2O)2](NO3); 4: [Cu(HL3)(L3)(H2O)2](NO3)
·H2O.
The fluorescence band maximum of HL3 is red-shifted with
respect to that of HL1; whereas the others are blue-shifted under
UV radiation. Different photophysical behaviour is observed
for HL3 (chloro derivative). The longer emission wavelength as
compared to the other benzimidazolyl-phenols indicates this
ligand has more extensive conjugation between the two
rings.44,45 All of the HL3 complexes show a blue shift in the fluores-
cence spectra as compared to the free ligand. It is interesting that
the Co(II) complex shows strong fluorescence at 452 nm whereas
the other complexes emit weak fluorescence near 430 nm.This
emission nature can be attributed to the ligand-centred charge
transfer transition (LCCT) with é Ã é* property.46
All of the compounds are fluorescent in the visible region.
Thus, these compounds have potential applications as lumines-
cent materials in light-emitting devices.
3.8. Antimicrobial Activity
The results concerning in vitro antimicrobial activity of the
ligands and the complexes together with MIC values of known
antibiotics and antifungal reagents are presented in Table 8.
It is observed that HL1, HL2, HL3 and [Cu(HL3)(L3)(H2O)2](NO3)·
H2O exhibit moderate antifungal activity toward C. albicans. In
addition, these four compounds show very weak antibacterial
activity against S. epidermidis (Gram+ bacteria). The latter two
compounds, HL3 and its Cu(II) complex, are also weakly effec-
tive against S. aureus (Gram+). HL3 exhibits a broader spectrum
of antimicrobial activity as compared to the other compounds.
HL4, nitro derivative, has no activity toward the microorganisms
(not reported). This situation can be related with the H-bonding
in the ligands: HL1, HL2 and HL3, which have relatively weaker
H-bonding as compared to HL4 (see IR Spectra Section), show
weak antimicrobial activity. According to this observation, there
may be a relation between hydrogen bonding and antimicrobial
activity of the ligands.
It is observed that the Cu(II) complex of HL3 has very weak
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Figure 5 The proposed structural representation for the studied complexes.
Table 7 Emission maximum wavelengths (nm) of the compounds.
Compound Emission maximum Compound Emission maximum
HL1 395 sh, 479 s a [Fe(L3)(OH)(H2O)3](NO3) 394 w, 430 w
HL2 394 sh, 475 s [Co(L3)(H2O)2](NO3) 378 sh, 452 s
HL3 394 w, 489 s [Cu(HL3)(L3)(H2O)2](NO3)·H2O 392 sh, 438 w
HL4 393 w, 461 m [Zn(L3)(H2O)2](NO3) 393 w, 440 w
a s, strong; m, medium; w, weak.
Table 8. In vitro antimicrobial activity of the compounds and the
standard reagents (MIC, µg mL–1).
Compound Microorganisms
Sa a Se Ca
HL1 –b 625 39
HL2 – 312 9.8
HL3 312 312 9.8
[C] c 625 625 19.5
Ciprofloxazin 0.125 156 –
Cefuroxime Na – 9.8 –
Fluconazole – – 1.0
a Sa, Staphylococcus aureus ATCC 6538; Se, Staphylococcus epidermidis ATCC 12228;
Ca, Candida albicans ATCC 10231.
b –: High MIC values (>625 µg mL–1).
c [C]: [Cu(HL3)(L3)(H2O)2](NO3)·H2O.
antibacterial activity and moderate antifungal activity, while the
other complexes are inactive. On the other hand, it should be
noted that the metal salts Fe(NO3)3, Cu(NO3)2, Co(NO3)2 and
Zn(NO3)2 did not show any effect on the microorganisms.
4. Conclusions
Benzimidazolyl-phenols are potential N, O donors and they
react easily with metal ions to give stable chelate complexes. In
this study, 3-(5-H/Me/Cl/NO2-1H-benzimidazol-2-yl)-ben-
zene-1,2-diols (HLX; X = 1–4) and HL3 complexes with Fe(NO3)3,
Cu(NO3)2, Co(NO3)2, Zn(NO3)2 have been synthesized and
characterized. All of the complexes fluoresce with the Co(II)
complex showing the highest fluorescence intensity, and higher
emission wavelength. Antibacterial activities of the ligands and
the complexes were evaluated using the disk diffusion method
against Staphylococcus aureus ATCC 6538, Staphylococcus epider-
midis ATCC 12228, Escherichia coli ATCC 8739, Klebsiella pneu-
moniae ATCC 4352, Pseudomonas aeruginosa ATCC 27853, Proteus
mirabilis ATCC 14153 and Candida albicans. It is observed that
HL3 exhibits a broader spectrum of antimicrobial activity as
compared to the other compounds. HL1, HL2, HL3 and
[Cu(HL3)(L3)(H2O)2](NO3)·H2O exhibit moderate antifungal
activity toward C. albicans and show very weak antibacterial
activity against S. epidermidis (Gram+ bacteria).
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